SCHEMBL16016629

SCHEMBL16016629

N#Cc1cc(-c2ccc(-c3cc(C#N)cc(-c4cccc5c4sc4ccccc45)c3)cc2)cc(-c2cccc3c2sc2ccccc23)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.55
PARP14 Q460N5 1/20 0.39
PRKDC P78527 5/20 0.39
GPR3 P46089 1/20 0.35
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
BRD4 O60885 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34
KCNH2 Q12809 1/20 0.34
BRDT Q58F21 1/20 0.34
PRSS12 P56730 1/20 0.34
LIMK1 P53667 1/20 0.34
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ADRA2C P18825 1/20 0.33
MAPT P10636 1/20 0.33
SLC22A12 Q96S37 2/20 0.32
PDK2 Q15119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16016653 0.99 ALOX5 (0.53) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL16016649 0.97 ALOX5 (0.52) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL16016596 0.97 ALOX5 (0.52) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL16016627 0.97 ALOX5 (0.52) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL19084352 0.97 ALOX5 (0.54) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL16016630 0.96 ALOX5 (0.54) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL16016628 0.96 ALOX5 (0.51) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL16016648 0.96 ALOX5 (0.50) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL21692330 0.96 ALOX5 (0.50) ALOX5PARP14PRKDCGPR3PIK3CD
SCHEMBL16016597 0.96 ALOX5 (0.50) ALOX5PARP14PRKDCGPR3PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217666-A1 Organic Electroluminescent Element And Novel Iridium Complex UDC IRELAND LTD (IE) 2023-07-06 US disclosed
US-20230217666-A1 Organic Electroluminescent Element And Novel Iridium Complex UDC IRELAND LTD (IE) 2023-07-06 US disclosed
US-20210057666-A1 Organic Electroluminescent Element And Novel Iridium Complex UDC IRELAND LTD (IE) 2021-02-25 US disclosed
US-10340471-B2 Organic electroluminescent element and novel iridium complex UDC IRELAND LIMITED (IE) 2019-07-02 US disclosed
US-20140252333-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL IRIDIUM COMPLEX Alexamdra House, The Sweepstakes (IE) 2014-09-11 US disclosed
US-20140252333-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL IRIDIUM COMPLEX Alexamdra House, The Sweepstakes (IE) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10340471-B2 Organic electroluminescent element and novel iridium complex CTCF, AP1M1, CLIC4 ALOX5 4098/4885PARP14 2230/4885PRKDC 3165/4885
US-20230217666-A1 Organic Electroluminescent Element And Novel Iridium Complex CTCF, AP1M1, CLIC4 ALOX5 3895/4885PARP14 2320/4885PRKDC 3398/4885
US-20210057666-A1 Organic Electroluminescent Element And Novel Iridium Complex CTCF, AP1M1, CLIC4 ALOX5 4098/4885PARP14 2230/4885PRKDC 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.